Oceanic Iron Ore Corp. (FEOVF)

Aerovate Therapeutics Balance Sheet

Financials in millions CAD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	1.37	1.42	0.27	0.66	0.29	0.05
Cash & Short-Term Investments	1.37	1.42	0.27	0.66	0.29	0.05
Cash Growth	533.23%	427.24%	-59.34%	126.09%	528.67%	-88.97%
Other Receivables	0.01	0.02	0.01	0.01	0	0
Receivables	0.01	0.02	0.01	0.01	0	0
Prepaid Expenses	0.03	0	0.01	0.01	0.01	0.01
Total Current Assets	1.42	1.44	0.29	0.68	0.31	0.06
Property, Plant & Equipment	44.95	44.9	44.45	44.18	43.91	43.61
Total Assets	46.37	46.34	44.74	44.85	44.22	43.66
Accounts Payable	0.29	0.26	0.34	0.35	0.24	0.35
Accrued Expenses	0.21	0.14	0.39	0.11	0.21	0.42
Current Portion of Long-Term Debt	15.2	9.13	3.45	1.08	1.16	-
Other Current Liabilities	0.34	0.32	0.31	0.26	0.27	0.45
Total Current Liabilities	16.05	9.85	4.49	1.79	1.88	1.22
Long-Term Debt	-	-	-	3.43	1.94	5.55
Other Long-Term Liabilities	0.44	0.42	0.42	0.42	0.42	0.43
Total Liabilities	16.48	10.26	4.91	5.65	4.25	7.2
Common Stock	63.38	63.16	62.37	61.89	61.63	61.32
Retained Earnings	-45	-38.55	-33.87	-33.92	-32.86	-35.96
Comprehensive Income & Other	11.51	11.47	11.33	11.24	11.21	11.11
Shareholders' Equity	29.89	36.08	39.83	39.21	39.98	36.47
Total Liabilities & Equity	46.37	46.34	44.74	44.85	44.22	43.66
Total Debt	15.2	9.13	3.45	4.51	3.1	5.55
Net Cash (Debt)	-13.83	-7.7	-3.18	-3.85	-2.81	-5.5
Net Cash Per Share	-0.12	-0.07	-0.03	-0.04	-0.02	-0.06
Filing Date Shares Outstanding	115.84	115.74	109.49	102.39	96.77	93.87
Total Common Shares Outstanding	115.74	114.33	106.52	99.73	96.67	93.87
Working Capital	-14.63	-8.4	-4.2	-1.11	-1.57	-1.16
Book Value Per Share	0.26	0.32	0.37	0.39	0.41	0.39
Tangible Book Value	29.89	36.08	39.83	39.21	39.98	36.47
Tangible Book Value Per Share	0.26	0.32	0.37	0.39	0.41	0.39

Source: S&P Global Market Intelligence. Standard template. Financial Sources.